Cytoreductive Surgery Offered by Expert Cancer Surgeons

The cancer surgeons of Surgical Oncology at Mercy are recognized experts in performing cytoreductive surgery in conjunction with hyperthermic intraperitoneal chemotherapy (HIPEC) to treat advanced stages of abdominal cancer.

What is Cytoreductive Surgery?

Cytoreductive surgery is the aggressive removal or destruction of the visible tumors in the abdomen. Performing cytoreductive surgery requires the expertise of an experienced surgeon. The length of the surgery depends on the amount of disease that is present.

The goal of cytoreductive surgery is to remove the visible tumors in the abdominal or stomach cavity. In some cases, microscopic cancer cells may be left behind. To prevent these cells from growing into larger tumors in the abdomen, the surgery is then followed by HIPEC.

Who should receive Cytoreductive Surgery?

Cytoreductive surgery performed in conjunction with HIPEC is a procedure for patients with peritoneal carcinomatosis (cancer in the abdomen area) that originated in the colon, rectum, stomach, appendix and ovaries, as well as mesotheliomas, sarcomas and primary peritoneal cancers.

Why have Cytoreductive Surgery at Mercy?

Mercy’s cancer surgeons and their clinical team are recognized nationally as leaders in aggressive cytoreductive surgery and HIPEC. Due to the complexity of the combined therapies, surgeons must be appropriately trained and experienced to offer these treatment methods.

The Surgical Oncology team at Mercy in Baltimore performs these procedures on a frequent basis and offers a high level of expertise to patients facing a diagnosis of peritoneal cancer.